4DMedical secures US$10m CTVQ orders in Philips deal
Filed with ASX · · 3 pages · English
Summary by 6ix AI
4DMedical Ltd. has announced a significant expansion of its distribution agreement with Philips for its CT:VQ™ technology, which is now included in Philips' North American product portfolio. The agreement includes a minimum order commitment from Philips, ensuring substantial revenue visibility for 4DMedical over the next two years. CT:VQ™ is a groundbreaking imaging solution that enhances lung health diagnostics by eliminating the need for radiotracers, thus streamlining the process. 4DMedical's CEO highlighted this partnership as a pivotal moment for the company, aiming to leverage Philips' resources to accelerate market adoption.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from 4DMedical
- CTVQ commercial rollout commences at Stanford
- 4DMedical secures $22.6 million via exercise of options
- Supplementary announcement - 4DX agreements
- 4DX signs agreements with national lung screening sites
- S&P DJI Announces September 2025 Quarterly Rebalance
Later from 4DMedical
- University of Miami adopts CTVQ
- 4DMedical secures $30.2 million with options underwrite
- 4DMedical secures regulatory approval for CTVQ in Canada
- Cleveland Clinic adopts CTVQ
- UC San Diego Health adopts CTVQ
Follow 4DMedical into a list and get an email when it puts out news.
Follow 4DMedical